HVCN1 and Parkinson disease: Here, we report that substantia nigra samples from post-mortem PD patients express higher mRNA levels of HVCN1 compared to age-matched controls, with PD males expressing 30% more HVCN1 compared to age-matched controls and no difference in female PD patients compared to controls.